Abbott to acquire Cephea Valve Technologies
Abbott announced it has exercised its option to purchase Cephea Valve Technologies, a privately held medical device company developing a less-invasive heart valve replacement technology for people with mitral valve disease. Financial terms were not disclosed. January 16, 2019